发明名称 |
V1A ARGININE VASOPRESSIN RECEPTOR DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO |
摘要 |
The present invention relates to compositions and methods relating to the characterization and function of V1a vasopressin receptor. Specifically, the present invention provides transgenic animals comprising disruptions in a V1a vasopressin receptor gene and methods of treating diseases conditions, such as schizophrenia, diabetes and inflammatory bowel disease. The present invention further relates to agents that modulate V1a vasopressin receptor and methods of screening for agents that modulate V1a vasopressin receptor for the treatment of diseases and conditions such as schizophrenia, diabetes and inflammatory bowel disease. |
申请公布号 |
WO03026398(A3) |
申请公布日期 |
2003.12.04 |
申请号 |
WO2002US30359 |
申请日期 |
2002.09.24 |
申请人 |
DELTAGEN, INC.;BRENNAN, THOMAS, J.;ZHANG, QIN |
发明人 |
BRENNAN, THOMAS, J.;ZHANG, QIN |
分类号 |
A01K;A01K67/027;C07K14/72;C12N5/06;C12N15/00;C12N15/85;G01N33/00 |
主分类号 |
A01K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|